Name: Latest research reports of Alkem Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Alkem Laboratories Ltd.
Rating: 1
Author: BOB Capital Markets Ltd.

Alkem Laboratories Ltd.

NSE: ALKEM | BSE: 539523 | ISIN: INE540L01014 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

5668.5000 25.00 (0.44%)

NSE Nov 07, 2025 15:31 PM

Near 52W High of ₹5786.90

Volume: 226.7K

Alkem Laboratories Ltd.

13 Feb 2023

5668.50

0.44%

Alkem Labs (SELL): Quarter buoyed by seasonal tailwinds

Sell: Alkem Laboratories Ltd.

Target

BOB Capital Markets Ltd.

Q3 revenue grew 16% YoY to Rs 30bn led by double-digit growth across markets; flu season drove US sales of US$ 92mn

Number of FII/FPI investors increased from 551 to 589 in Sep 2025 qtr.